tildren

Bisphosphonates: What We Know About Off-Label Use, And What One Drug Company Is Doing About It

A little more than a year ago, top surgeon Dr. Larry Bramlage stood up in Rood and Riddle’s annual Client Education Seminar and issued a warning to attendees about a new group of drugs called bisphosphonates. Bramlage worried the drug was being misused, and that misuse was putting racehorses at serious, long-term risk of injury […]

Continue reading
CBA: ‘Off Label’ Use Of Bisphosphonates In Young Horses Is Unacceptable

The use of bisphosphonates in young horses is a hot-button issue with the recent rash of breakdowns at Santa Anita Park, and last week the Thoroughbred Horsemen’s Association began pushing for rules that would partially ban bisphosphonates. The drug, commercially known as Osphos or Tildren and used to treat  symptoms of navicular disease, is not […]

Continue reading
View From The Eighth Pole: Take Action Now On Bisphosphonates Use

“I’ve been Tildrened.” That’s what a consignor of 2-year-olds said recently to a leading owner about a horse he purchased at a yearling sale with the intention of putting it in training and re-selling it as a prospective racehorse this spring. He was referring to the potentially negative side-effects from a drug called Tildren, one […]

Continue reading
Painting Leads To A New Lease On Life For Retired Racehorse

Once a well-known racehorse, Metro Meteor, owned by Ron and Wendy Krajewski, took on an unusual new career once his racing days were over: painting. Bone chips in his knees ended his racing career, and rehabilitation, medication and custom shoes couldn’t stop his knee joints from beginning to fuse. Complete closure of the knee joint […]

Continue reading
FDA Approval Of Bisphosphonates Provides Treatment Options For Navicular Pain

Although bisphosphonates are becoming known in the racing world as a new drug of regulatory concern, a report on Spin to Win Rodeo indicates that some veterinarians are finding the medications useful for laminitis treatment when used appropriately. Osphos, the American-made version of Tildren, was approved by the FDA last year for use in non-breeding adult horses, […]

Continue reading
Twitter Twitter
Paulick Report on Instagram